Study on the Carcinogenesis of Gα12 in Oral Cancer, and the Treatment of Oral Cancer Using Ga12 Inhibitor.

Immunonutrition Supplementation in Head and Neck Cancer Patients Undergoing Cancer Treatment Study

NCT05526040 ·Status: UNKNOWN ·Phase: NA

A Study of TC(Docetaxel and Carboplatin) Regimen With or Without Nimotuzumab in Recurrent Metastatic Oral Squamous Cell Carcinoma

NCT04367909 ·Status: UNKNOWN ·Phase: PHASE2

WGA in Platinum-refractory HNSCC Underwent Nivolumab

NCT03917537 ·Status: UNKNOWN

Postoperative CCRT With Docetaxel vs Cisplatin in High Risk Oral Cavity Cancer

NCT02923258 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Primary Tumor Depth of Invasion and Lymph Node Management in Oral Squamous Cell Carcinoma

NCT07127614 ·Status: NOT_YET_RECRUITING

Post-Operative Adjuvant Concurrent Chemoradiotherapy For High Risk Oral Cavity Squamous Cell Carcinoma Patients

NCT00201383 ·Status: COMPLETED ·Phase: PHASE3

Optimized Intensity Modulated Irradiation for Head and Neck Cancer

NCT00580983 ·Status: COMPLETED ·Phase: NA

Comparison the Effects of Different Neoadjuvant Chemotherapy Regimen on Acute Toxicity, Tumor Response, and Survival in Patients With Advanced Nasopharyngeal Carcinoma

NCT02500940 ·Status: UNKNOWN ·Phase: PHASE3

Real-world Analysis on the Efficacy and Safety of Neoadjuvant Therapy for Head and Neck Squamous Cell Carcinoma （neoHNSCC）

NCT06011993 ·Status: UNKNOWN

Role of Neo-adjuvant Chemotherapy in Tongue Preservation in Locally Advanced Squamous Cell Carcinoma of Oral Tongue

NCT02985255 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Evaluate the Impact of Maintaining Hemoglobin Levels in Anemic Patients With Carcinoma of the Cervix

NCT00921635 ·Status: SUSPENDED ·Phase: PHASE3

The Efficacy and Safety of Pucotenlimab Combined With TP Chemotherapy as Neoadjuvant Therapy for Locally Advanced HNSCC

NCT06895369 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Head and Neck Cancer Treatment Patterns and Outcomes Research Study in France, Germany, and Canada

NCT02705833 ·Status: COMPLETED

Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Cognitive Function in Patients With Resectable Head and Neck Squamous Cell Carcinoma

NCT06576180 ·Status: RECRUITING

Preoperative TPF Chemotherapy in Molecularly Selected Locally Advanced Resectable Oral Cavity Squamous Cell Cancer

NCT01914900 ·Status: COMPLETED ·Phase: PHASE2

Rituximab Plus Chemotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

NCT04361409 ·Status: COMPLETED ·Phase: PHASE1

Anti-tumor Specific Immune Response in Head and Neck Cancers

NCT02881918 ·Status: UNKNOWN

Real-Life Effectiveness and Safety in Participants With Advanced/Metastatic Renal Cell Carcinoma Starting 1st Line Nivolumab and Ipilimumab Combination Therapy or Nivolumab Monotherapy After Prior Therapy

NCT02940639 ·Status: COMPLETED

Comparing Postoperative Adjuvant Cisplatin Concurrent Chemoradiotherapy With Adjuvant Radiotherapy Alone for Intermediate-risk Head and Neck Squamous Cell Carcinoma

NCT07125755 ·Status: RECRUITING ·Phase: PHASE3

Non-randomized, Open-label Study of Intralesional Nivolumab for High Risk Oral Premalignant Lesions

NCT05327270 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Bone Marrow Protective Effect of Trilaciclib in Postoperative CCRT for LA-HNSCC

NCT06752798 ·Status: RECRUITING ·Phase: PHASE2

Tertiary Prevention of Head and Neck Cancer With a Dietary Intervention

NCT02869399 ·Status: COMPLETED ·Phase: NA

Postoperative Concurrent Chemoradiation for Head and Neck Cancer With Multiple Minor Risk

NCT00937612 ·Status: TERMINATED ·Phase: NA

Time to Treatment and Disease-free Survival of Patients With High-risk Head-neck Cutaneous Squamous Cell Carcinoma

NCT05845632 ·Status: UNKNOWN

Neoadjuvant Immunochemotherapy and Postoperative Adjuvant Immunotherapy for Head and Neck Squamous Cell Carcinoma Invading the Skull Base

NCT07145931 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2